Recreational nitrous oxide and thrombotic events: a case series

IF 2.1 Q3 CLINICAL NEUROLOGY BMJ Neurology Open Pub Date : 2024-05-01 DOI:10.1136/bmjno-2023-000619
Marta Patyjewicz, Devan Mair, Safiya A Zaloum, Barbara Onen, Joseph Walton, Ruth Dobson, Christine Joerres, Apeksha Madhusudan Shah, Peter MacCallum, Thomas H Massey, T. Bariana, Veronica White, Sarah A De Freitas, Alastair J Noyce
{"title":"Recreational nitrous oxide and thrombotic events: a case series","authors":"Marta Patyjewicz, Devan Mair, Safiya A Zaloum, Barbara Onen, Joseph Walton, Ruth Dobson, Christine Joerres, Apeksha Madhusudan Shah, Peter MacCallum, Thomas H Massey, T. Bariana, Veronica White, Sarah A De Freitas, Alastair J Noyce","doi":"10.1136/bmjno-2023-000619","DOIUrl":null,"url":null,"abstract":"Background The study aimed to elucidate the prevalence of nitrous oxide (N2O) usage in patients with unexplained venous thromboembolism (VTE), highlighting the potential association with hyperhomocysteinaemia (HHcy). Methods We conducted a retrospective study at the Royal London Hospital, examining cases of N2O-related VTE from March to August 2023. Among 50 patients identified, four (8%) had recent unprovoked VTE. Patient data were collected based on N2O ambulatory emergency care pathway admissions. Results Among the 50 patients identified, four (8%) had recent or concurrent VTE. Three were male (75%), with an ethnic distribution of 50% Asian or Asian British and 50% Black or Black British. Patients were distributed across quintiles of the index of multiple deprivation. All had actual or functional vitamin B12 deficiency. Discussion The association between N2O use and VTE requires further investigation, though a plausible mechanism involving HHcy has been proposed. Clinicians should be vigilant for VTE in N2O users, especially those presenting with unexplained symptoms. VTE prophylaxis may be worth considering, particularly if continued exposure to nitrous oxide is anticipated. Conclusion N2O misuse may increase the risk of VTE, warranting attention from healthcare providers. Further research is needed to elucidate this association and inform preventive strategies. Public awareness about the risks of N2O remains essential.","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Neurology Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjno-2023-000619","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background The study aimed to elucidate the prevalence of nitrous oxide (N2O) usage in patients with unexplained venous thromboembolism (VTE), highlighting the potential association with hyperhomocysteinaemia (HHcy). Methods We conducted a retrospective study at the Royal London Hospital, examining cases of N2O-related VTE from March to August 2023. Among 50 patients identified, four (8%) had recent unprovoked VTE. Patient data were collected based on N2O ambulatory emergency care pathway admissions. Results Among the 50 patients identified, four (8%) had recent or concurrent VTE. Three were male (75%), with an ethnic distribution of 50% Asian or Asian British and 50% Black or Black British. Patients were distributed across quintiles of the index of multiple deprivation. All had actual or functional vitamin B12 deficiency. Discussion The association between N2O use and VTE requires further investigation, though a plausible mechanism involving HHcy has been proposed. Clinicians should be vigilant for VTE in N2O users, especially those presenting with unexplained symptoms. VTE prophylaxis may be worth considering, particularly if continued exposure to nitrous oxide is anticipated. Conclusion N2O misuse may increase the risk of VTE, warranting attention from healthcare providers. Further research is needed to elucidate this association and inform preventive strategies. Public awareness about the risks of N2O remains essential.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
娱乐性氧化亚氮与血栓事件:病例系列
背景 该研究旨在阐明不明原因静脉血栓栓塞症(VTE)患者使用一氧化二氮(N2O)的普遍性,并强调其与高半胱氨酸血症(HHcy)的潜在关联。方法 我们在伦敦皇家医院进行了一项回顾性研究,检查了 2023 年 3 月至 8 月期间与 N2O 相关的 VTE 病例。在确定的 50 例患者中,有 4 例(8%)近期发生过无诱因 VTE。患者数据是根据 N2O 非住院急诊路径入院情况收集的。结果 在确定的 50 名患者中,有 4 人(8%)近期或同时患有 VTE。其中三人为男性(75%),种族分布为50%亚裔或亚裔英国人,50%黑人或黑人英国人。患者分布在多重贫困指数的五分位数中。所有患者均患有实际或功能性维生素 B12 缺乏症。讨论 使用 N2O 与 VTE 之间的关系还需要进一步研究,尽管有人提出了涉及 HHcy 的合理机制。临床医生应警惕 N2O 使用者出现 VTE,尤其是出现不明症状者。VTE 预防措施值得考虑,尤其是在预计将继续接触氧化亚氮的情况下。结论 误用一氧化二氮可能会增加罹患 VTE 的风险,值得医疗保健提供者注意。需要进一步研究来阐明这种关联,并为预防策略提供依据。提高公众对一氧化二氮风险的认识仍然至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BMJ Neurology Open
BMJ Neurology Open Medicine-Neurology (clinical)
CiteScore
3.20
自引率
3.70%
发文量
46
审稿时长
13 weeks
期刊最新文献
Assessing insomnia after stroke: a diagnostic validation of the Sleep Condition Indicator in self-reported stroke survivors. Major vascular events after first incident stroke: a population-based study. Minimising the rate of vascular complications in Deep Brain Stimulation surgery for the management of Parkinson's disease: a single-centre 600-patient case series. Development and internal validation of prehospital prediction models for identifying intracerebral haemorrhage in suspected stroke patients. Review of theories into the pathogenesis of normal pressure hydrocephalus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1